Clot retrieval for stroke should be restricted to clinical trials: No

Stroke

Volumn 41, Issue 1, 2010, Pages 194-195

  Furlan, Anthony J ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROUROKINASE;

BLOOD CLOT LYSIS; BLOOD CLOT RETRACTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; PRIORITY JOURNAL; STROKE; UNITED STATES;

CLINICAL TRIALS AS TOPIC; HUMANS; STROKE; THROMBOLYTIC THERAPY;

EID: 74049143131     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.569913     Document Type: Note

References (12)

1. Hirsch JA, Yoo AJ, Nogueira RG, Verduzco LA, Schwamm LH, Pryor JC, Rabinov JD, González RG. Case volumes of intra-arterial and intravenous treatment of ischemic stroke in the USA. J Neurointerv Surg. 2009;1:27-31.
2. Spodick DH. Numerators without denominators: there is no FDA for the surgeon. JAMA. 1975;232:35-36.
3. Furlan AJ, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA. 1999;282:2003-2011.
4. Furlan AJ, Fisher M. Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke. 2005;36: 398-399.
5. Furlan AJ. Ethics and feasibility of placebo-controlled interventional acute stroke trials. Stroke. 23 Jul 2009 [Epub ahead of print].
6. Köhrmann M, Schwab S. Response to letter by Furlan. Stroke. 23 Jul 2009 [Epub ahead of print].
7. Grotta J, Barreto AD. A response to letters by Furlan, and Kohrmann and Schwab. Stroke. 23 Jul 2009 [Epub ahead of print]
8. Off label practices plague circulatory system device randomized trials. The FDC Reports. The Gray Sheet. Vol 30. May 17, 2004.
9. Meyers PM, Schumacher HC, Alexander MJ, Derdeyn CP, Furlan AJ, Higashida RT, Moran CJ, Tarr RW, Heck DV, Hirsch JA, Jensen ME, Linfante I, McDougall CG, Nesbit GM, Rasmussen PA, Tomsick TA, Wechsler LR, Wilson JR, Zaidat OO. Performance and training standards for endovascular ischemic stroke treatment. J Neurointerv Surg. 2009;1: 10-12.
10. Levin S. Concentric Medical: breaking the stroke device barrier. In Vivo: The Business and Medicine Report. Winhover Information, Inc. October 2004; Vol 18, No.9.
11. Liebeskind DS. Reversing stroke in the 2010s. Lessons from Des-moteplase in Acute Ischemic Stroke-2 (DIAS-2). Stroke. 16 Jul 2009 [Epub ahead of print].
12. Soares BP, Chien JD, Wintermark M. MR and CT monitoring of recan-alization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke. 2009;40:S24-S27.